Obesity is a growing problem worldwide, with over 1 billion people now considered obese. This has led to an increase in demand for drugs to address this condition, and companies like Novo Nordisk and Eli Lilly have seen a surge in market value due to their innovative weight-loss medications.
The Economist Podcast examines the impact of these drugs on both the pharmaceutical industry and the global economy. Hosts Alice Fulwood, Mike Bird, and Tom Lee-Devlin unpack the topic with expert guests including The Economist’s Georgia Banjo, pharmaceuticals analyst Michael Nedelcovych, and John Cawley, a professor at Cornell University.
The podcast covers a wide range of topics from global politics and business to science and technology. Subscribe now to stay informed and up-to-date on what matters most in the world. To get access to Economist Podcasts+, visit the FAQs page or watch a video on how to link your account.
For those interested in podcast transcripts, simply reach out to [email protected] to request them. The Economist is dedicated to improving accessibility and is exploring new ways to expand the podcast-transcript offering. Listen to the podcast on Apple Podcasts or Spotify to stay informed on the latest global trends and discussions.
